The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
This report contains market size and forecasts of Infectious Diseases Molecular Diagnostics Kit in Global, including the following market information:
Global Infectious Diseases Molecular Diagnostics Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Diseases Molecular Diagnostics Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases Molecular Diagnostics Kit include Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics and DAAN Gene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Diseases Molecular Diagnostics Kit companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases Molecular Diagnostics Kit Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, by Type, 2021 (%)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Other
Global Infectious Diseases Molecular Diagnostics Kit Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, by Application, 2021 (%)
Hospital
Third-party Testing Agency
Other
Global Infectious Diseases Molecular Diagnostics Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Infectious Diseases Molecular Diagnostics Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases Molecular Diagnostics Kit revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Diseases Molecular Diagnostics Kit revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine